# Angiocrine Bioscience (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/angiocrine-bioscience-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 22 |
| Citations | 3,669 |
| City | San Diego |
| Country | US |
| Description | Angiocrine Bioscience (United States) is a research organisation in San Diego, US. OpenAlex records 95 works and 3,669 citations for it. 47 researchers list it as their most recent affiliation. |
| Homepage | http://angiocrinebioscience.com/ |
| OpenAlex ID | https://openalex.org/I4210114959 |
| Researchers | 47 |
| ROR ID | https://ror.org/02hpd7j03 |
| Type | company |
| Works | 95 |

## University papers

- [Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis](https://scholariq.org/papers/pharmacokinetics-pharmacodynamics-and-safety-of-apixaban-in-subjects-with-end/)
- [Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects](https://scholariq.org/papers/safety-pharmacokinetics-and-pharmacodynamics-of-multiple-oral-doses-of-apixaban/)
- [Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects](https://scholariq.org/papers/effect-of-extremes-of-body-weight-on-the-pharmacokinetics-pharmacodynamics/)
- [Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban](https://scholariq.org/papers/effect-of-renal-impairment-on-the-pharmacokinetics-pharmacodynamics-and-safety/)
- [Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study](https://scholariq.org/papers/clinical-and-biological-predictors-of-response-to-standardised-paediatric/)
- [Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor<scp>X</scp>a inhibitor](https://scholariq.org/papers/effect-of-ketoconazole-and-diltiazem-on-the-pharmacokinetics-of-apixaban-an-oral/)
- [Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects](https://scholariq.org/papers/effect-of-activated-charcoal-on-apixaban-pharmacokinetics-in-healthy-subjects/)
- [Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor](https://scholariq.org/papers/chromogenic-laboratory-assays-to-measure-the-factor-xa-inhibiting-properties-of/)
- [A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban](https://scholariq.org/papers/a-randomized-direct-comparison-of-the-pharmacokinetics-and-pharmacodynamics-of/)
- [Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa](https://scholariq.org/papers/effect-of-rifampin-on-the-pharmacokinetics-of-apixaban-an-oral-direct-inhibitor/)
- [Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis](https://scholariq.org/papers/treatment-outcomes-associated-with-dupilumab-use-in-patients-with-atopic/)

## University researchers

- [Jessie Wang](https://scholariq.org/researchers/jessie-wang/)

## University top topics

Showing 8 of 25.

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)
- [Single-cell and spatial transcriptomics](https://scholariq.org/topics/single-cell-and-spatial-transcriptomics/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.